Cem Akin spends much of his time researching Immunology, Systemic mastocytosis, Mast cell, Mast cell leukemia and Urticaria pigmentosa. His Immunology study deals with Internal medicine intersecting with Oncology. His Cutaneous Mastocytosis study, which is part of a larger body of work in Systemic mastocytosis, is frequently linked to Population, bridging the gap between disciplines.
His study in Mast cell is interdisciplinary in nature, drawing from both Molecular biology and Stem cell factor. Cem Akin has included themes like Cancer research, Imatinib, Midostaurin and Kinase activity in his Mast cell leukemia study. His work deals with themes such as Eosinophilia, Hypereosinophilic syndrome, Disease and Histamine, which intersect with Tryptase.
The scientist’s investigation covers issues in Immunology, Systemic mastocytosis, Mast cell, Tryptase and Internal medicine. His Immunology research is multidisciplinary, incorporating perspectives in Haematopoiesis and Disease. Cem Akin frequently studies issues relating to Urticaria pigmentosa and Systemic mastocytosis.
His Mast cell study also includes fields such as
Systemic mastocytosis, Mast cell, Mast cell activation syndrome, Immunology and Tryptase are his primary areas of study. His work in the fields of Systemic mastocytosis, such as Cutaneous Mastocytosis and Kit d816v, overlaps with other areas such as In patient. In the field of Mast cell, his study on Mast cell leukemia overlaps with subjects such as Diagnostic methods.
His Mast cell activation syndrome research includes elements of Bronchoconstriction, Medical diagnosis, Abdominal pain and Bioinformatics. His Immunology study combines topics in areas such as Patient perceptions and Histamine. His studies in Tryptase integrate themes in fields like Somatic cell, Bone marrow and Midostaurin.
Cem Akin mostly deals with Systemic mastocytosis, Mast cell activation syndrome, Tryptase, Mast cell and Anaphylaxis. His study on Systemic mastocytosis is covered under Disease. He combines subjects such as Medical diagnosis, Cutaneous Mastocytosis and Bioinformatics with his study of Mast cell activation syndrome.
His Tryptase study necessitates a more in-depth grasp of Immunology. His Immunology research incorporates elements of Phenotype and Progenitor cell. His research in Mast cell is mostly focused on Mast cell leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley.
Leukemia Research (2001)
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
P. Valent;C. Akin;L. Escribano;M. Födinger.
European Journal of Clinical Investigation (2007)
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI
Arnold S. Kirshenbaum;Cem Akin;Yalin Wu;Menachem Rottem.
Leukemia Research (2003)
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.
Yongsheng Ma;Shan Zeng;Dean D. Metcalfe;Cem Akin.
Blood (2002)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Peter Valent;Cem Akin;Michel Arock;Knut Brockow.
International Archives of Allergy and Immunology (2012)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent;Cem Akin;Dean D. Metcalfe.
Blood (2017)
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
Amy D. Klion;Amy D. Klion;Pierre Noel;Pierre Noel;Cem Akin;Cem Akin;Melissa A. Law;Melissa A. Law.
Blood (2003)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides;Peter Valent;Cem Akin.
The New England Journal of Medicine (2015)
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
Cem Akin;Gerard Fumo;Akif S. Yavuz;Peter E. Lipsky.
Blood (2004)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin.
The New England Journal of Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institute of Allergy and Infectious Diseases
Medical University of Vienna
Stanford University
Brigham and Women's Hospital
Université Paris Cité
University Medical Center Groningen
Virginia Commonwealth University
University of Salerno
Technical University of Munich
University of Salamanca
Tencent (China)
University of Leicester
National Technical University of Athens
Wuhan University
University of Göttingen
Ahvaz Jundishapur University of Medical Sciences
University of Cambridge
Victoria University of Wellington
Centre d’Immunologie de Marseille-Luminy
Baylor College of Medicine
Humboldt-Universität zu Berlin
University College London
Harvard Medical School
University of California, Irvine
Walter and Eliza Hall Institute of Medical Research
University College London